Nifty
Sensex
:
:
18696.10
62868.50
-116.40 (-0.62%)
-415.69 (-0.66%)

Pharmaceuticals & Drugs

Rating :
49/99

BSE: 500259 | NSE: LYKALABS

137.85
01-Dec-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 141.00
  • 144.95
  • 135.00
  • 139.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  125963
  •  177.54
  •  267.00
  •  102.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 395.64
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 508.73
  • N/A
  • 28.76

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 47.59%
  • 3.87%
  • 37.72%
  • FII
  • DII
  • Others
  • 0.57%
  • 4.00%
  • 6.25%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.32
  • 26.54
  • 46.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.72
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.10
  • -0.47
  • -2.26

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 97.31
  • 146.76
  • 134.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
25.53
73.89
-65.45%
27.49
49.44
-44.40%
35.19
24.26
45.05%
35.57
26.81
32.67%
Expenses
20.50
28.26
-27.46%
21.19
19.54
8.44%
22.58
18.02
25.31%
22.55
20.80
8.41%
EBITDA
5.03
45.63
-88.98%
6.30
29.90
-78.93%
12.60
6.24
101.92%
13.02
6.02
116.28%
EBIDTM
19.70%
61.76%
22.92%
60.48%
35.82%
25.73%
36.60%
22.43%
Other Income
1.19
0.69
72.46%
0.72
0.47
53.19%
0.53
0.55
-3.64%
0.41
0.29
41.38%
Interest
3.03
5.57
-45.60%
2.91
6.93
-58.01%
2.99
6.37
-53.06%
4.64
6.59
-29.59%
Depreciation
3.62
3.52
2.84%
3.59
2.13
68.54%
9.46
2.02
368.32%
2.24
2.12
5.66%
PBT
-0.64
33.33
-
0.76
21.31
-96.43%
-2.11
-2.65
-
6.72
-1.99
-
Tax
-0.30
5.66
-
0.05
1.83
-97.27%
12.88
-4.22
-
0.44
-0.14
-
PAT
-0.34
27.68
-
0.71
19.48
-96.36%
-14.99
1.57
-
6.28
-1.86
-
PATM
-1.34%
37.45%
2.58%
39.41%
-42.60%
6.48%
17.65%
-6.92%
EPS
-0.13
9.91
-
0.21
6.81
-96.92%
-5.25
0.40
-
2.12
-0.79
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Net Sales
123.78
194.08
86.25
61.49
70.78
59.81
110.08
130.41
166.27
118.86
127.12
Net Sales Growth
-29.03%
125.02%
40.27%
-13.13%
18.34%
-45.67%
-15.59%
-21.57%
39.89%
-6.50%
 
Cost Of Goods Sold
50.31
52.97
37.97
35.79
39.25
29.38
53.85
70.43
90.74
64.14
66.90
Gross Profit
73.47
141.11
48.28
25.70
31.54
30.43
56.23
59.98
75.53
54.72
60.22
GP Margin
59.36%
72.71%
55.98%
41.80%
44.56%
50.88%
51.08%
45.99%
45.43%
46.04%
47.37%
Total Expenditure
86.82
92.94
66.57
65.16
72.68
63.36
87.31
110.25
137.62
110.32
105.56
Power & Fuel Cost
-
3.92
2.94
2.56
2.28
1.86
1.90
1.39
2.06
3.11
1.91
% Of Sales
-
2.02%
3.41%
4.16%
3.22%
3.11%
1.73%
1.07%
1.24%
2.62%
1.50%
Employee Cost
-
18.06
14.57
13.86
14.69
16.98
17.24
14.71
17.26
16.39
13.80
% Of Sales
-
9.31%
16.89%
22.54%
20.75%
28.39%
15.66%
11.28%
10.38%
13.79%
10.86%
Manufacturing Exp.
-
4.20
3.00
1.73
1.32
1.06
1.20
1.24
1.93
1.46
2.00
% Of Sales
-
2.16%
3.48%
2.81%
1.86%
1.77%
1.09%
0.95%
1.16%
1.23%
1.57%
General & Admin Exp.
-
6.29
4.31
5.70
5.91
5.81
5.96
6.62
7.42
5.90
5.74
% Of Sales
-
3.24%
5.00%
9.27%
8.35%
9.71%
5.41%
5.08%
4.46%
4.96%
4.52%
Selling & Distn. Exp.
-
5.75
2.65
2.27
5.17
2.95
0.37
8.61
13.20
11.03
8.85
% Of Sales
-
2.96%
3.07%
3.69%
7.30%
4.93%
0.34%
6.60%
7.94%
9.28%
6.96%
Miscellaneous Exp.
-
1.74
1.14
3.24
4.07
5.31
6.80
7.25
5.00
8.29
8.85
% Of Sales
-
0.90%
1.32%
5.27%
5.75%
8.88%
6.18%
5.56%
3.01%
6.97%
5.00%
EBITDA
36.95
101.14
19.68
-3.67
-1.90
-3.55
22.77
20.16
28.65
8.54
21.56
EBITDA Margin
29.85%
52.11%
22.82%
-5.97%
-2.68%
-5.94%
20.68%
15.46%
17.23%
7.18%
16.96%
Other Income
2.85
2.09
1.56
3.09
2.09
2.13
2.24
2.06
2.35
5.37
3.35
Interest
13.57
20.13
25.94
20.07
7.17
9.58
18.72
16.42
25.57
28.53
20.78
Depreciation
18.91
17.35
8.32
8.01
7.31
11.28
10.25
9.32
10.87
8.80
11.70
PBT
4.73
65.77
-13.02
-28.66
-14.29
-22.28
-3.97
-3.52
-5.44
-23.43
-7.56
Tax
13.07
20.80
-4.05
0.74
-9.07
-1.04
-1.51
-0.19
1.06
1.25
0.00
Tax Rate
276.32%
35.11%
28.62%
-1.20%
58.78%
5.19%
18.62%
-4.86%
-28.96%
-30.79%
0.00%
PAT
-8.34
39.00
-11.55
-60.54
-5.55
-17.21
-5.54
3.69
-4.95
-6.59
-0.71
PAT before Minority Interest
-8.76
38.44
-10.09
-62.62
-6.35
-19.00
-6.60
4.09
-4.72
-5.30
0.41
Minority Interest
-0.42
0.56
-1.46
2.08
0.80
1.79
1.06
-0.40
-0.23
-1.29
-1.12
PAT Margin
-6.74%
20.09%
-13.39%
-98.46%
-7.84%
-28.77%
-5.03%
2.83%
-2.98%
-5.54%
-0.56%
PAT Growth
-117.79%
-
-
-
-
-
-
-
-
-
 
EPS
-2.91
13.59
-4.02
-21.09
-1.93
-6.00
-1.93
1.29
-1.72
-2.30
-0.25

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Shareholder's Funds
13.34
-25.80
-14.34
43.02
49.47
37.71
45.24
43.06
52.71
66.95
Share Capital
28.69
28.69
28.69
28.14
28.14
22.04
23.13
22.67
22.67
22.67
Total Reserves
-15.35
-54.49
-43.03
14.12
20.57
15.67
22.11
20.07
30.05
44.29
Non-Current Liabilities
72.77
148.88
136.67
72.28
5.28
38.68
28.52
36.95
65.16
71.93
Secured Loans
0.86
150.65
125.45
78.39
4.06
34.93
25.31
28.92
50.33
53.58
Unsecured Loans
61.63
0.71
0.64
0.90
0.87
0.84
0.00
0.00
7.67
13.65
Long Term Provisions
3.47
3.66
3.86
4.08
3.63
4.39
2.92
4.30
4.20
3.85
Current Liabilities
99.35
49.88
66.32
84.81
167.12
165.45
162.83
195.24
208.09
147.21
Trade Payables
12.00
14.71
18.85
23.23
24.21
39.16
42.08
54.64
63.26
43.31
Other Current Liabilities
66.25
23.10
30.83
43.31
92.38
73.07
56.55
79.41
77.72
44.17
Short Term Borrowings
20.07
10.37
14.41
16.26
45.82
50.23
59.95
59.85
66.20
58.78
Short Term Provisions
1.05
1.70
2.23
2.02
4.72
2.99
4.26
1.35
0.91
0.96
Total Liabilities
185.61
173.66
187.88
202.85
225.23
248.87
240.50
278.76
329.26
288.90
Net Block
93.96
98.19
104.78
107.73
116.04
132.90
104.23
121.64
162.45
124.69
Gross Block
169.37
202.50
188.36
202.81
155.31
144.01
200.41
213.51
248.18
195.12
Accumulated Depreciation
75.41
104.31
83.58
95.08
39.27
11.11
96.18
91.87
85.73
70.43
Non Current Assets
133.42
144.59
152.00
167.75
176.16
186.07
158.70
177.08
211.17
162.24
Capital Work in Progress
17.74
25.76
27.76
31.07
27.88
24.23
30.17
27.03
21.78
15.38
Non Current Investment
0.01
0.01
0.01
0.01
0.23
0.26
0.39
0.32
0.30
5.53
Long Term Loans & Adv.
21.71
20.63
19.46
28.94
32.01
28.69
23.92
28.09
26.65
16.64
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
52.20
29.08
35.88
35.11
49.07
62.79
81.81
101.69
118.09
126.66
Current Investments
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
8.20
4.31
6.73
7.00
11.20
13.24
10.81
19.25
15.83
18.07
Sundry Debtors
18.45
8.67
8.04
14.63
20.50
29.17
43.29
56.70
68.02
73.40
Cash & Bank
17.05
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
4.80
Other Current Assets
8.49
4.73
6.54
2.13
14.95
15.25
22.14
19.23
23.54
30.38
Short Term Loans & Adv.
5.62
4.21
4.26
9.64
13.21
10.92
17.22
14.57
18.24
16.56
Net Current Assets
-47.15
-20.80
-30.44
-49.70
-118.05
-102.66
-81.03
-93.55
-90.00
-20.55
Total Assets
185.62
173.67
187.88
202.86
225.23
248.86
240.51
278.77
329.26
288.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Cash From Operating Activity
79.25
8.81
5.32
26.67
10.88
31.38
11.95
26.54
89.10
10.94
PBT
59.25
-14.14
-61.88
-15.42
-20.04
-8.10
3.69
-4.95
-6.59
-0.71
Adjustment
41.93
35.40
55.76
15.17
20.79
30.53
16.15
31.64
32.87
17.41
Changes in Working Capital
-21.01
-11.64
10.94
27.65
10.36
10.10
-7.57
-0.79
66.90
-5.46
Cash after chg. in Working capital
80.16
9.62
4.82
27.39
11.10
32.53
12.27
25.90
93.17
11.24
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.92
-0.81
0.50
-1.10
-0.44
-1.20
-0.33
-0.10
1.02
-0.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.12
Extra & Other Items
0.00
0.00
0.00
0.37
0.23
0.06
0.00
0.74
-5.10
0.00
Cash From Investing Activity
-6.17
-0.16
-0.11
-3.97
-3.17
-12.67
17.29
28.99
-56.87
4.54
Net Fixed Assets
-2.28
-20.42
-43.81
-2.41
-3.63
12.94
-4.69
29.40
-9.46
-11.12
Net Investments
0.00
0.00
30.05
-0.01
0.00
0.12
0.00
-0.04
-42.31
0.00
Others
-3.89
20.26
13.65
-1.55
0.46
-25.73
21.98
-0.37
-5.10
15.66
Cash from Financing Activity
-63.18
-11.80
3.38
-23.42
-10.41
-19.15
-30.19
-59.72
-26.32
-12.52
Net Cash Inflow / Outflow
9.90
-3.15
8.60
-0.72
-2.69
-0.43
-0.96
-4.20
5.91
2.97
Opening Cash & Equivalents
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
4.80
1.83
Closing Cash & Equivalent
17.05
7.15
10.30
1.70
2.43
5.12
5.56
6.51
10.71
4.80

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Book Value (Rs.)
4.65
-8.99
-5.00
15.02
16.78
15.82
16.94
14.99
18.55
25.87
ROA
21.40%
-5.58%
-32.05%
-2.97%
-8.02%
-2.70%
1.58%
-1.55%
-1.72%
0.14%
ROE
0.00%
0.00%
-448.65%
-14.20%
-46.30%
-18.27%
11.74%
-13.05%
-11.06%
0.73%
ROCE
56.68%
8.95%
-31.39%
-5.50%
-6.52%
6.66%
12.41%
11.73%
11.93%
10.68%
Fixed Asset Turnover
1.04
0.44
0.31
0.40
0.41
0.68
0.65
0.75
0.57
0.70
Receivable days
25.51
35.37
67.29
90.56
149.54
113.31
136.29
132.10
204.83
183.49
Inventory Days
11.76
23.36
40.77
46.92
73.58
37.61
40.97
37.15
49.11
46.62
Payable days
92.01
161.35
117.58
127.84
181.43
174.53
168.94
158.77
188.04
138.63
Cash Conversion Cycle
-54.74
-102.62
-9.53
9.65
41.69
-23.60
8.32
10.48
65.90
91.48
Total Debt/Equity
9.76
-6.30
-9.85
2.28
2.39
3.60
3.12
4.05
3.97
2.62
Interest Cover
3.94
0.45
-2.08
-1.15
-1.09
0.57
1.24
0.86
0.86
1.02

News Update:


  • Lyka Labs - Quarterly Results
    9th Nov 2022, 13:41 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.